JPMORGAN CHASE & CO - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 266 filers reported holding CYTOKINETICS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$11,374,535
-7.0%
386,101
+3.0%
0.00%0.0%
Q2 2023$12,232,663
-2.4%
375,005
+5.3%
0.00%
-50.0%
Q1 2023$12,529,739
+87772.5%
356,070
+14.4%
0.00%0.0%
Q4 2022$14,259
-99.9%
311,198
+34.3%
0.00%0.0%
Q3 2022$11,229,000
+22.5%
231,775
-0.6%
0.00%
+100.0%
Q2 2022$9,163,000
+282.7%
233,213
+258.6%
0.00%
Q1 2022$2,394,000
-2.2%
65,026
+21.0%
0.00%
Q4 2021$2,448,000
+94.9%
53,727
+52.9%
0.00%
Q3 2021$1,256,000
+113.2%
35,145
+17.9%
0.00%
Q2 2021$589,000
+1.2%
29,799
+19.1%
0.00%
Q1 2021$582,000
-5.2%
25,021
-15.2%
0.00%
Q4 2020$614,000
-87.3%
29,518
-86.3%
0.00%
-100.0%
Q3 2020$4,828,000
+36.9%
216,210
+44.5%
0.00%0.0%
Q2 2020$3,526,000
-2.1%
149,601
-51.0%
0.00%0.0%
Q1 2020$3,603,000
+219.1%
305,610
+187.4%
0.00%
Q4 2019$1,129,000
+442.8%
106,354
+482.7%
0.00%
Q3 2019$208,000
-56.4%
18,252
-57.6%
0.00%
Q2 2019$477,000
+424.2%
43,036
+283.7%
0.00%
Q1 2019$91,000
+23.0%
11,217
-4.5%
0.00%
Q4 2018$74,000
-29.5%
11,744
+10.3%
0.00%
Q3 2018$105,000
+36.4%
10,650
+14.1%
0.00%
Q2 2018$77,000
-90.5%
9,336
-91.7%
0.00%
Q1 2018$809,000
+13.6%
112,399
+28.6%
0.00%
Q4 2017$712,000
+23633.3%
87,385
+31108.9%
0.00%
Q2 2016$3,000
+50.0%
2800.0%0.00%
Q1 2016$2,0000.0%280
+56.4%
0.00%
Q4 2015$2,000
-99.1%
179
-99.4%
0.00%
Q3 2013$224,00029,5620.00%
Other shareholders
CYTOKINETICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
BVF INC/IL 2,106,989$14,159,0002.50%
Healthcare Value Capital, LLC 100,000$672,0000.71%
First Light Asset Management, LLC 218,792$1,470,0000.69%
IRONWOOD INVESTMENT MANAGEMENT LLC 435,202$2,925,0000.67%
TFS CAPITAL LLC 899,951$6,048,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 422,250$2,838,0000.28%
ALGERT GLOBAL LLC 73,181$492,0000.27%
LANSDOWNE PARTNERS (UK) LLP 2,321,865$15,603,0000.13%
Leisure Capital Management 17,567$118,0000.12%
Rotella Capital Management, Inc. 15,778$106,0000.09%
View complete list of CYTOKINETICS INC shareholders